Complement and Toll-like receptors: key regulators of adaptive immune responses.

[1]  Y. Belkaid,et al.  C5a negatively regulates toll-like receptor 4-induced immune responses. , 2005, Immunity.

[2]  J. Lambris,et al.  The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo , 2005, The Journal of experimental medicine.

[3]  T. Mcclanahan,et al.  IL-23 drives a pathogenic T cell population that induces autoimmune inflammation , 2005, The Journal of experimental medicine.

[4]  P. Ward,et al.  Role of C5a in inflammatory responses. , 2005, Annual review of immunology.

[5]  C. Hunter,et al.  The role of IL‐27 in the development of T‐cell responses during parasitic infections , 2004, Immunological reviews.

[6]  R. de Waal Malefyt,et al.  IL‐12 and IL‐23: master regulators of innate and adaptive immunity , 2004, Immunological reviews.

[7]  Y. Zohar,et al.  Suppression of Ongoing Experimental Autoimmune Encephalomyelitis by Neutralizing the Function of the p28 Subunit of IL-271 , 2004, The Journal of Immunology.

[8]  John D Lambris,et al.  Complement C5a Receptor Is Essential for the Optimal Generation of Antiviral CD8+ T Cell Responses1 , 2004, The Journal of Immunology.

[9]  R. Geha,et al.  The anaphylatoxin C3a downregulates the Th2 response to epicutaneously introduced antigen. , 2004, The Journal of clinical investigation.

[10]  Y. Zohar,et al.  Suppression of Ongoing Adjuvant-Induced Arthritis by Neutralizing the Function of the p28 Subunit of IL-27 , 2004, The Journal of Immunology.

[11]  C. Hunter,et al.  Understanding the Pro- and Anti-Inflammatory Properties of IL-271 , 2004, The Journal of Immunology.

[12]  Shizuo Akira,et al.  Toll-like receptor signalling , 2004, Nature Reviews Immunology.

[13]  J. Köhl,et al.  The anaphylatoxins bridge innate and adaptive immune responses in allergic asthma. , 2004, Molecular immunology.

[14]  M. Carroll,et al.  The complement system in B cell regulation. , 2004, Molecular immunology.

[15]  T. Fujita,et al.  The lectin‐complement pathway – its role in innate immunity and evolution , 2004, Immunological reviews.

[16]  M. Walport,et al.  The role of complement in the development of systemic lupus erythematosus. , 2004, Annual review of immunology.

[17]  T. Mcclanahan,et al.  WSX-1 and Glycoprotein 130 Constitute a Signal-Transducing Receptor for IL-27 , 2004, The Journal of Immunology.

[18]  K. Schroder,et al.  Interferon- : an overview of signals, mechanisms and functions , 2004 .

[19]  T. Mcclanahan,et al.  Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation , 2003, The Journal of experimental medicine.

[20]  M. Fenton,et al.  TLRs: differential adapter utilization by toll-like receptors mediates TLR-specific patterns of gene expression. , 2003, Molecular interventions.

[21]  N. Sarvetnick,et al.  Cytokines and autoimmunity: redundancy defines their complex nature. , 2003, Current opinion in immunology.

[22]  F. D. de Sauvage,et al.  IL-27 regulates IL-12 responsiveness of naïve CD4+ T cells through Stat1-dependent and -independent mechanisms , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[23]  G. Trinchieri,et al.  The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. , 2003, Immunity.

[24]  P. Kaye,et al.  Natural antibodies and complement are endogenous adjuvants for vaccine-induced CD8+ T-cell responses , 2003, Nature Medicine.

[25]  Persephone Borrow,et al.  Viral infection switches non-plasmacytoid dendritic cells into high interferon producers , 2003, Nature.

[26]  T. Mak,et al.  Cutting Edge: Role of IL-27/WSX-1 Signaling for Induction of T-Bet Through Activation of STAT1 During Initial Th1 Commitment1 , 2003, The Journal of Immunology.

[27]  G. Núñez,et al.  Cell death and immunity: NODs: intracellular proteins involved in inflammation and apoptosis , 2003, Nature Reviews Immunology.

[28]  Eric M. Billings,et al.  F(ab)′2-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins , 2003, Nature Medicine.

[29]  A. Malik,et al.  Toll-like receptor-4 (TLR4) signaling augments chemokine-induced neutrophil migration by modulating cell surface expression of chemokine receptors , 2003, Nature Medicine.

[30]  R. Kastelein,et al.  Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain , 2003, Nature.

[31]  G. Trinchieri,et al.  Interleukin-12 and the regulation of innate resistance and adaptive immunity , 2003, Nature Reviews Immunology.

[32]  K. Murphy,et al.  Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype , 2003, Nature.

[33]  John D Lambris,et al.  Complement Component 3 Is Required for Optimal Expansion of CD8 T Cells During a Systemic Viral Infection1 , 2003, The Journal of Immunology.

[34]  D. Corry,et al.  Absence of the Complement Anaphylatoxin C3a Receptor Suppresses Th2 Effector Functions in a Murine Model of Pulmonary Allergy1 , 2002, The Journal of Immunology.

[35]  A. Sher,et al.  Evasion of innate immunity by parasitic protozoa , 2002, Nature Immunology.

[36]  John D Lambris,et al.  Protection of innate immunity by C5aR antagonist in septic mice , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[37]  C. Rabourdin-Combe,et al.  Linking innate and acquired immunity: divergent role of CD46 cytoplasmic domains in T cell–induced inflammation , 2002, Nature Immunology.

[38]  T. Mcclanahan,et al.  IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells. , 2002, Immunity.

[39]  S. Sacks,et al.  Local synthesis of complement component C3 regulates acute renal transplant rejection , 2002, Nature Medicine.

[40]  Charles A. Janeway,et al.  Decoding the Patterns of Self and Nonself by the Innate Immune System , 2002, Science.

[41]  M. Shlomchik,et al.  Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors , 2002, Nature.

[42]  M. Bachmann,et al.  Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection , 2002, Nature Medicine.

[43]  Ralph Weissleder,et al.  Arthritis critically dependent on innate immune system players. , 2002, Immunity.

[44]  T. Mak,et al.  WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection. , 2001, Immunity.

[45]  J. Köhl,et al.  Anaphylatoxins and infectious and non-infectious inflammatory diseases. , 2001, Molecular immunology.

[46]  M. Walport,et al.  Complement. Second of two parts. , 2001, The New England journal of medicine.

[47]  M. Walport.  Complement. First of two parts. , 2001, The New England journal of medicine.

[48]  J. Prechl,et al.  Adjuvant effect of γ‐inulin is mediated by C3 fragments deposited on antigen‐presenting cells , 2001, Journal of Leukocyte Biology.

[49]  F. Murad,et al.  Cutting Edge: Targeted Disruption of the C3a Receptor Gene Demonstrates a Novel Protective Anti-Inflammatory Role for C3a in Endotoxin-Shock1 , 2000, The Journal of Immunology.

[50]  R. Ames,et al.  Cutting Edge: Guinea Pigs with a Natural C3a-Receptor Defect Exhibit Decreased Bronchoconstriction in Allergic Airway Disease: Evidence for an Involvement of the C3a Anaphylatoxin in the Pathogenesis of Asthma1 , 2000, The Journal of Immunology.

[51]  J Wagner,et al.  Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. , 2000, Immunity.

[52]  G. Peltz,et al.  Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma , 2000, Nature Immunology.

[53]  Bao Lu,et al.  A role for the C3a anaphylatoxin receptor in the effector phase of asthma , 2000, Nature.

[54]  D. Taub,et al.  Early Local Generation of C5a Initiates the Elicitation of Contact Sensitivity by Leading to Early T Cell Recruitment1 , 2000, The Journal of Immunology.

[55]  B. Kelsall,et al.  Selective Suppression of IL-12 Production by Chemoattractants , 2000, The Journal of Immunology.

[56]  D. Fearon,et al.  Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. , 2000, Annual review of immunology.

[57]  Sam,et al.  Early IL‐12 p70, but not p40, production by splenic macrophages correlates with host resistance to blood‐stage Plasmodium chabaudi AS malaria , 1999, Clinical and experimental immunology.

[58]  O. Götze,et al.  C5a suppresses the production of IL-12 by IFN-gamma-primed and lipopolysaccharide-challenged human monocytes. , 1999, Journal of immunology.

[59]  F. Malavasi,et al.  rC5a directs the in vitro migration of human memory and naive tonsillar B lymphocytes: implications for B cell trafficking in secondary lymphoid tissues. , 1999, Journal of immunology.

[60]  J. Köhl,et al.  Site-directed C3a receptor antibodies from phage display libraries. , 1998, Journal of immunology.

[61]  T. Hugli,et al.  Characterization of Complement Anaphylatoxins and Their Biological Responses , 1998 .

[62]  J. Volanakis.  The human complement system in health and disease , 1998 .

[63]  W. Fischer,et al.  Regulation of B cell functions by C3a and C3a(desArg): suppression of TNF-alpha, IL-6, and the polyclonal immune response. , 1997, Journal of immunology.

[64]  B. Kelsall,et al.  Regulation of Interleukin-12 by Complement Receptor 3 Signaling , 1997, The Journal of experimental medicine.

[65]  A. Ganser,et al.  The Human C3a Receptor Is Expressed on Neutrophils and Monocytes, but Not on B or T Lymphocytes , 1997, The Journal of experimental medicine.

[66]  P. Ward,et al.  C5a-dependent up-regulation in vivo of lung vascular P-selectin. , 1997, Journal of immunology.

[67]  Q. Hu,et al.  Amelioration of lupus-like autoimmune disease in NZB/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[68]  G. Trinchieri,et al.  Mechanism of Suppression of Cell-Mediated Immunity by Measles Virus , 1996, Science.

[69]  C. Dinarello,et al.  A new biologic role for C3a and C3a desArg: regulation of TNF-alpha and IL-1 beta synthesis. , 1996, Journal of immunology.

[70]  B. Jakschik,et al.  Neutrophil elicitation in the reverse passive Arthus reaction. Complement-dependent and -independent mast cell involvement. , 1994, Journal of immunology.

[71]  T. Hugli,et al.  Induction of interleukin-8 synthesis from monocytes by human C5a anaphylatoxin. , 1994, The American journal of pathology.

[72]  D. Noonan,et al.  C5a-mediated release of interleukin 6 by human monocytes. , 1990, Clinical immunology and immunopathology.

[73]  E. Berg,et al.  Neutrophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors. , 1989, Science.

[74]  F. Gervais,et al.  The C5-sufficient A/J congenic mouse strain. Inflammatory response and resistance to Listeria monocytogenes. , 1989, Journal of immunology.

[75]  C. Janeway.  Approaching the asymptote? Evolution and revolution in immunology. , 1989, Cold Spring Harbor symposia on quantitative biology.

[76]  C. Dinarello,et al.  C5a induction of human interleukin 1. Synergistic effect with endotoxin or interferon-gamma. , 1987, Journal of immunology.

[77]  D. Bitter‐Suermann,et al.  Guinea pigs with inherited deficiencies of complement components C2 or C4 have characteristics of immune complex disease. , 1986, The Journal of clinical investigation.

[78]  D. Bitter‐Suermann,et al.  Impaired humoral immune response in complement C3‐deficient guinea pigs: absence of secondary antibody response , 1986, European journal of immunology.

[79]  R. Clancy,et al.  Complement-mediated arachidonate metabolism. , 1985, Progress in biochemical pharmacology.

[80]  M. Pepys.  ROLE OF COMPLEMENT IN INDUCTION OF ANTIBODY PRODUCTION IN VIVO , 1974, The Journal of experimental medicine.

[81]  H. Müller-Eberhard,et al.  THE DERIVATION OF TWO DISTINCT ANAPHYLATOXIN ACTIVITIES FROM THE THIRD AND FIFTH COMPONENTS OF HUMAN COMPLEMENT , 1968, The Journal of experimental medicine.